FN2 Earnings Intelligence
GE HealthCare Technologies Inc. ratios (quarterly)
GE HealthCare Technologies Inc. (GEHC) Ratios (quarterly) derived from persisted SEC financial facts.
Key Stats
USD in millions, except per-share values and percentages.
| Metric | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 | 9/30/2026 est. | 12/31/2026 est. |
|---|---|---|---|---|---|---|---|
| Market Cap | - | - | - | - | - | - | - |
| - Cash | $2,454 | $3,737 | $4,005 | $2,261 | $2,079 | - | - |
| + Debt | $8,759 | $10,275 | $10,282 | $10,134 | $10,093 | - | - |
| Enterprise Value | - | - | - | - | - | - | - |
| Revenue | $4,777 | $5,007 | $5,143 | $5,131 | $5,295 | $5,406.6 | $5,984.3 |
| % Growth | - | - | - | - | - | 5.1% | - |
| Gross Profit | $2,012 | $1,985 | $1,990 | $1,977 | $2,180 | - | - |
| % Margin | 42.1% | 39.6% | 38.7% | 38.5% | 41.2% | - | - |
| EBITDA | $695 | $712 | $710 | $593 | $806 | - | - |
| % Margin | 14.5% | 14.2% | 13.8% | 11.6% | 15.2% | - | - |
| Net Income | $564 | $486 | $446 | $389 | $561 | - | - |
| % Margin | 11.8% | 9.7% | 8.7% | 7.6% | 10.6% | - | - |
| Diluted EPS | $1.23 | $1.06 | $0.98 | $0.85 | $1.24 | $1.24 | $1.62 |
| % Growth | - | - | - | - | - | 27.0% | - |
| Operating Cash Flow | $250 | - | - | $290 | - | - | - |
| CapEx | $152 | - | - | $178 | - | - | - |
| Free Cash Flow | $98 | - | - | $112 | - | - | - |
Historical market capitalization is not persisted, so Market Cap and Enterprise Value remain unavailable rather than mixing today's market value into prior periods.
Income Statement
USD in millions, except per-share values and percentages.
| Metric | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 | 9/30/2026 est. | 12/31/2026 est. |
|---|---|---|---|---|---|---|---|
| Revenue | $4,777 | $5,007 | $5,143 | $5,131 | $5,295 | $5,406.6 | $5,984.3 |
| Gross Profit | $2,012 | $1,985 | $1,990 | $1,977 | $2,180 | - | - |
| EBITDA | $695 | $712 | $710 | $593 | $806 | - | - |
| Net Income | $564 | $486 | $446 | $389 | $561 | - | - |
| Diluted EPS | $1.23 | $1.06 | $0.98 | $0.85 | $1.24 | $1.24 | $1.62 |
Balance Sheet
USD in millions, except per-share values and percentages.
| Metric | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 |
|---|---|---|---|---|---|
| Cash & Equivalents | $2,454 | $3,737 | $4,005 | $2,261 | $2,079 |
| Short-term Debt | $2,002 | $2,005 | $2,005 | $7 | $2 |
| Long-term Debt | $6,757 | $8,270 | $8,277 | $10,127 | $10,091 |
| Total Debt | $8,759 | $10,275 | $10,282 | $10,134 | $10,093 |
Cash Flow
USD in millions, except per-share values and percentages.
| Metric | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 |
|---|---|---|---|---|---|
| Operating Cash Flow | $250 | - | - | $290 | - |
| Capital Expenditure | $152 | - | - | $178 | - |
| Free Cash Flow | $98 | - | - | $112 | - |
Ratios
USD in millions, except per-share values and percentages.
| Metric | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 |
|---|---|---|---|---|---|
| Revenue Growth | - | - | - | - | - |
| Gross Margin | 42.1% | 39.6% | 38.7% | 38.5% | 41.2% |
| EBITDA Margin | 14.5% | 14.2% | 13.8% | 11.6% | 15.2% |
| Net Margin | 11.8% | 9.7% | 8.7% | 7.6% | 10.6% |
| FCF Margin | 2.1% | - | - | 2.2% | - |
| Diluted EPS Growth | - | - | - | - | - |